Shelley Thunen Buys Shares of LENZ Therapeutics, Inc. $LENZ
Key Points
- Shelley Thunen bought 22,100 shares of LENZ Therapeutics, Inc. ($LENZ).
- $LENZ last traded around $6.63.
Shelley Thunen, insider at LENZ Therapeutics, Inc. ($LENZ), bought 22,100 shares at an average price of $0.00. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
LENZ Therapeutics, Inc. ($LENZ) Stock
LENZ Therapeutics, Inc. Earnings
Analysts Set New Price Targets
About LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.